期刊文献+

嗜酸乳杆菌联合三联方案根除幽门螺杆菌的效果分析 被引量:2

Clinical value of eradicating Helicobacter pylori by lactobacillus acidophilus combined with proton pump inhibitors
下载PDF
导出
摘要 目的通过嗜酸乳杆菌联合标准三联方案5周疗法,探讨嗜酸乳杆菌对提高三联方案幽门螺杆菌(Helicobacter pylori,H.pylori)根除率的作用。方法分析我院消化内科门诊H.pylori阳性初治患者134例临床资料。将134例患者分为治疗组和对照组,治疗组采用嗜酸乳杆菌+标准三联方案5周疗法,对照组采用标准三联方案1周疗法。结果所有患者均按时完成治疗,完成随访的117例患者中,治疗组61例,治愈53例,治愈率86.9%;对照组56例,治愈40例,治愈率71.4%;两组比较有统计学差异(P<0.05)。结论嗜酸乳杆菌能提高三联方案H.pylori根除率,患者服药副作用小,依从性好,具有应用价值。 Objective To evaluate the clinical value of eradicating Helicobacter pylori by lactobacillus acidophilus for 5 weeks combined with proton pump inhibitors. Methods 134 previously untreated H. pylori-positive patients were selected in the gastroenterology clinic of our hospital. All patients were randomly divided into treatment group and control group. The medicine containing lactobacillus acidophilus was taken in treatment group from the first week to the five weeks. And the PPI three-drug regimen was added in the third week. The control group was treated by only PPI threedrug regimen. Results All patients accomplished the therapy in plan. The cure rates were 86.9% (53/61) in treatment group and 71.4% (40/56) in the control group. There was statistically significant difference between the treatment group and the control group (P 〈 0.05). Conclusion The method of the lactobacillus acidophilus combined with proton pump inhibitors is a regimen with higher efficacy and lower toxicity.
出处 《胃肠病学和肝病学杂志》 CAS 2013年第2期133-134,共2页 Chinese Journal of Gastroenterology and Hepatology
关键词 幽门螺杆菌 嗜酸乳杆菌 质子泵抑制剂 治愈率 Helicobacter pylori Lactobacillus acidophilus Proton pump inhibitors Cure rate
  • 相关文献

参考文献8

  • 1Szajewska H,Horvath A,Piwowarczyk A. Meta-analysis:the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment[J].Alimentary Pharmacology and Therapeutics,2010,(09):1069-1079.
  • 2Sachdeva A,Nagpal J. Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication:a systematic review and meta-analysis of randomized-controlled trials[J].European Journal of Gastroenterology and Hepatology,2009,(01):45-53.
  • 3de Bortoli N,Leonardi G,Ciancia E. Helicobacter pylori eradication:a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics[J].American Journal of Gastroenterology,2007,(05):951-956.
  • 4Tong JL,Ran ZH,Shen J. Meta-analysis:the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy[J].Alimentary Pharmacology and Therapeutics,2007,(02):155-168.
  • 5杜弈奇.益生菌可有效提高H.pylori根除率.第六届幽门螺杆菌感染及消化疾病诊治临床论坛荟萃pylori根除率.第六届幽门螺杆菌感染及消化疾病诊治临床论坛荟萃[N].医师报,2011.
  • 6赵东,徐桂芳,邹晓平.益生菌对感染幽门螺杆菌的C57BL/6小鼠胃黏膜IL-8、IFN-γ以及IL-4、IL-10的调节效应[J].胃肠病学,2012,17(5):271-275. 被引量:40
  • 7萧树东;许国铭.中华胃肠病学[M]北京:人民卫生出版社,2008507.
  • 8Hunt RH,Xiao SD,Megraud F. Helicobacter pylori in developing countries.World Gastroenterology Organisation Global Guideline[J].J Gastrointest Liver Dis,2011,(03):299-304.

二级参考文献18

  • 1Johnson-Henry KC, Mitchell DJ, Avitzur Y, et al. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice [ J ]. Dig Dis Sci, 2004, 49 (7-8) : 1095-1102.
  • 2Sgouras D, Maragkoudakis P, Petraki K, et al. In vitro and in vivo inhibition of Helicobacter pylori by LactobaciUuscasei strain Shirota[ J]. Appl Environ Microbiol, 2004, 70 ( 1 ) : 518-526.
  • 3Sgouras DN, Panayotopoulou EG, Martinez-Gonzalez B, et al. l.zwtobacillus johnsonii Lal attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BIZ6 mice [ J ]. Clin Diagn Lab Immunol, 2005, 12 (12) : 1378-1386.
  • 4Sheu BS, Wu J J, Lactobacillus- and Lo CY, et al. Impact of supplement with yogurt on triple therapy for Helicobacter pylori eradication [ J ]. Aliment Pharmacol Ther, 2002, 16 (9) : 1669-1675.
  • 5Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study [ J ]. Am J Gastroenterol, 2002, 97 ( 11 ) : 2744-2749.
  • 6Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 [ J]. Am J Surg Pathol, 1996, 20 (10): 1161-1181.
  • 7de Bortoli N, Leonardi G, Ciancia E, et al. Helicobacter pylori eradication : a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics [J]. Am J Gastroenterol, 2007, 102 (5) : 951-956.
  • 8Tong JL, Ran ZI-I, Shen J, et al. Meta-analysis : the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy[J]. Aliment Pharmacol Ther, 2007, 25 (2): 155-168.
  • 9Sachdeva A, Nagpal J. Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized- controlled trials [ J ]. Eur J Gastroenterol Hepatol, 2009, 21 (1) : 45-53.
  • 10Szajewska H, Horvath A, Piwowarczyk A. Meta-analysis: the effects of Saccharomyces boulardii supplementation onHelicobacter pylori eradication rates and side effects during treatment[J]. Aliment Pharmacol Ther, 2010, 32 (9): 1069-1079.

共引文献39

同被引文献43

引证文献2

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部